Furthermore, in the presence of elevated ALT among older patients without diabetes, statin use emerged as a subsequent key factor in differentiating the risk of liver cancer, where uncontrolled LDL cholesterol and male sex were identified as dominant risk factors in statin users and nonstatin users, respectively. The gene discussed is GPT; the disease is diabetes mellitus.